We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

91 hedge funds and large institutions have $134M invested in BioSpecifics Technologies Corp. in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 33

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 95 → 91 (-4)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

24% less capital invested

Capital invested by funds: $177M → $134M (-$43M)

Holders
91
Holders Change
-4
Holders Change %
-4.21%
% of All Funds
2.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
34
Reduced
33
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
+$1.46M
2
RHJA
Rice Hall James & Associates
California
+$1.28M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.12M
4
RA
Royce & Associates
New York
+$1.04M
5
OAM
Oxford Asset Management
United Kingdom
+$951K

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$4.81M
2
ACA
Abdiel Capital Advisors
New York
-$4.47M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$4.21M
4
Ameriprise
Ameriprise
Minnesota
-$2.36M
5
Invesco
Invesco
Georgia
-$1.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$1.56M – – –
Invesco
27
Invesco
Georgia
$1.54M -$1.21M -33,074 -43%
First Manhattan
28
First Manhattan
New York
$1.51M +$606K +16,500 +61%
DCM
29
DAFNA Capital Management
California
$1.38M +$1.46M +39,704 New
TCIM
30
TIAA CREF Investment Management
New York
$1.36M -$273K -7,440 -16%
AQR Capital Management
31
AQR Capital Management
Connecticut
$1.29M +$142K +3,856 +12%
PI
32
Putnam Investments
Massachusetts
$1.24M +$26.8K +729 +2%
American Century Companies
33
American Century Companies
Missouri
$1.23M +$72.5K +1,976 +6%
Goldman Sachs
34
Goldman Sachs
New York
$1.18M -$5.72K -156 -0.5%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$1.03M +$202K +5,500 +23%
Prudential Financial
36
Prudential Financial
New Jersey
$1M +$146K +3,966 +16%
SCM
37
Stonepine Capital Management
Oregon
$893K +$941K +25,637 New
BA
38
BlackRock Advisors
Delaware
$886K +$16.3K +444 +2%
BCM
39
Bridgeway Capital Management
Texas
$868K -$1.83K -50 -0.2%
MCM
40
Matarin Capital Management
New York
$843K +$651K +17,738 +274%
HIP
41
Hatteras Investment Partners
North Carolina
$771K -$21.7K -590 -3%
BIM
42
Bogle Investment Management
Massachusetts
$714K +$753K +20,530 New
TAM
43
Tocqueville Asset Management
New York
$696K – – –
Millennium Management
44
Millennium Management
New York
$683K +$516K +14,073 +254%
BIM
45
BlackRock Investment Management
Delaware
$615K +$17.4K +475 +3%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$584K – – –
Deutsche Bank
47
Deutsche Bank
Germany
$495K -$15.9K -434 -3%
GA
48
Geneva Advisors
Illinois
$464K -$143K -3,892 -23%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$412K +$110K +2,992 +34%
ACM
50
Ativo Capital Management
Illinois
$397K – – –
1
2
3 4 5

BSTC Hedge Fund Activity: Q1 2016 in Review

91 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2016, worth a combined $134M — down 24% from $177M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of BSTC and 12 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 34 added.

The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $1.46M. The largest seller was EAM Investors, exiting entirely with an estimated $4.81M sold.

  • 91 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2016, down from 95 in Q4 2015.
  • Funds reported $134M of BioSpecifics Technologies Corp. stock for Q1 2016, down 24% quarter-over-quarter.
  • 12 funds opened new BioSpecifics Technologies Corp. positions in Q1 2016 and 15 closed out, a net change of -3 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q1 2016 was DAFNA Capital Management, an estimated $1.46M added.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2016 was EAM Investors, an estimated $4.81M sold.

Based on aggregated 13F filings for Q1 2016.